Madrigal Pharmaceuticals

-$1.85 (-2.35%) As of 2:58 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MDGL and other ETFs, options, and stocks.

About MDGL

Madrigal Pharmaceuticals, Inc. engages on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia.

CEO
Paul A. Friedman
Employees
42
Headquarters
West Conshohocken, Pennsylvania
Founded
2011

MDGL Key Statistics

Market cap
1.31B
Price-Earnings ratio
—
Dividend yield
—
Average volume
130.01K
High today
$78.52
Low today
$76.08
Open price
$78.52
Volume
8.19K
52 Week high
$142.62
52 Week low
$74.18

MDGL Earnings

-$3.90
-$2.60
-$1.30
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Feb 24, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure